Do you know the latest trends in Pharmacovigilance in Asia?
Worth of Asia’s Pharmaceutical Market
Of 18 – 24-year-olds trust medical information shared on social media
More than 100
Approved drugs with labels that contain information on genomic biomarkers
Highest fine to date for off-label promotion
This lucrative market in Asia remains extremely complicated and fast changing. Make sure you arm yourself with the latest information to stay ahead of your competitors…
Elevating PV Quality and Compliance via Community Collaboration and Digital Health Applications
The 7th Annual Pharmacovigilance Asia Summit once again gathers global and regional regulators together with industry experts to tackle the latest challenges in proactively building and managing a risk-management programme. What are the new quantitative methods in benefit-risk evaluation? How do you create a PV-focused culture and what is the role of the QPPV in Asia? How has digital health initiatives had an impact on the cost and accuracy of PV? How do you leverage on mobile applications to enhance medication adherence and patient support compliance?
We’ll be answering these questions and more as we bring together experts from Europe and APAC!
Learn from academic and health authority speakers
InnovatOrri Pharma Consulting
Associate Director of Pharmacovigilance
Merck Sharp And Dohme (MSD)
Director Medical Governance Quality & Risk Management
GlaxoSmithKline Pharmaceuticals Limited
National University of Singapore
Director, Regional Labeling Head for Asia
Local Safety Responsible
Roche, (Philippines) Inc.
Chief Medical Officer, Vice President and General Manager
Eisai Co., Ltd.
Vice President- Pharmacovigilance & Global Head
Head of Pharmacovigilance Asia Pacific & China
Bayer South-East Asia (Singapore)
Associate Director, Global Pharmacovigilance Operations,
Takeda Global Research & Development Center Asia Private Limited
Regional Head Pharmacovigilance Oversight - APAC
Country Safety Team Lead
Johnson & Johnson
Technical Vice Director
Vietnam National Centre for Drug Information and ADR Monitoring
Head of Health Product Vigilance Center
Head of Pharmacovigilance Section
National Pharmaceutical Regulatory Agency (NPRA), Malaysia (formerly known as National Pharmaceutical Control Bureau)
Head, Sub-Directorate of Surveillance and Risk Analysis of Therapeutic Prod
Indonesia National Agency of Drug and Food Control (NADFAC)
Key Topics in 2016 Include:
The latest PV legislationhow will developments in US and Europe affect Asia?
Leveraging digital health applicationsto enhance patient support through detecting and managing safety signals and enhance patient support
Pro-actively negotiating risk management plansand benefit-risk evaluation in Asia – both quantitative and qualitative approaches
Creating a PV-focused cultureand ensuring quality assurance across people, process and technologies
Ensuring continuity and compliancein M&A environment
How to effectively communicate riskthrough education, awareness, and collaboration with the community
Top Reasons to Attend
Covering the breadth of international and regional regulatory bodies – European Medical Agency (EMA), and non ICH countries across Asia Pacific
ONLY Asia event unveiling the latest updates from ISoP’s Special Interest Group on Risk Minimisation Methods in Asia
Exclusive: special hands-on mobile application evaluation session where you get to try your hand at the latest digital PV technologies
Derive a holistic understanding from both very technical (beginner) levels and more advanced and strategic points of view
In-depth case studies from leading companies in the region and interactive multi-stakeholder debates
“Simple enough for a beginner, complex enough for the experienced. Brilliant!”
“Very well organised conference. Attendee mix was nice – including industry and regulators! Well done!”
“This conference offers the opportunity for those working in pharmacovigilance to share expertise and learn about best practices and challenge the way they do things.”
"Had an overall understanding of pharmacovigilance running in Asia, particularly in ASEAN. It is helpful for me to make a plan locally and accelerate pharmacovigilance strategy locally.”
"The IQPC Pharmacovigilance conference in Singapore, which is becoming an annual event is, to my knowledge, the most comprehensive information exchange and discussion forum dedicated to pharmacovigilance held in Asia so far.”
Emerging Tools for Data Collection
While the use of social media monitoring and PV apps are already underway in the USA, in this article we ask how effective are these practices and when will they become commonplace in Asia?